RE FRANCESCA

Amenta, A., Comi, S., Kravicz, M., Sesana, S., Antoniou, A., Passarella, D., et al. (2025). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy. RSC MEDICINAL CHEMISTRY [10.1039/d4md00517a]. Detail

Sierri, G., Saenz-De-Santa-Maria, I., Renda, A., Koch, M., Sommi, P., Anselmi-Tamburini, U., et al. (2025). Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells. NANOSCALE, 17(2), 992-1006 [10.1039/d4nr03174a]. Detail

Kravicz, M., Taiarol, L., Viegas, J., Sierri, G., Mauri, M., Koch, M., et al. (2024). Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 101(Part A November 2024) [10.1016/j.jddst.2024.106238]. Detail

Rivara, M., Nicolini, G., Malacrida, A., Re, F., Incerti, M., Russo, G., et al. (2024). New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma. RESULTS IN CHEMISTRY, 9(July 2024) [10.1016/j.rechem.2024.101645]. Detail

Shaik, M., Pasco, S., Romerio, A., Pifferi, C., Sesana, S., Re, F., et al. (2024). Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant. JOURNAL OF MEDICINAL CHEMISTRY, 67(24), 22254-22262 [10.1021/acs.jmedchem.4c02392]. Detail